Particle.news
Download on the App Store
6 ARTICLES
·
3w ago

Judge Approves Revised Purdue–Sackler Opioid Settlement Requiring Up To $7 Billion

Victim payments depend on proof of OxyContin prescriptions under a plan that prioritizes public abatement.

FILE - Jayde Newton helps to set up cardboard gravestones with the names of victims of opioid abuse outside the courthouse where the Purdue Pharma bankruptcy is taking place in White Plains, N.Y., on Aug. 9, 2021. (AP Photo/Seth Wenig, File)
FILE - "Pill Man" made by Frank Huntley of Worcester, Mass., from his opioid prescription pill bottles, is displayed during a protest by advocates for opioid victims outside the Department of Justice, Dec. 3, 2021, in Washington. (AP Photo/Carolyn Kaster, File)
FILE - Fake pill bottles with messages about OxyContin maker Purdue Pharma are displayed during a protest outside the courthouse where the bankruptcy of the company is taking place in White Plains, N.Y., on Aug. 9, 2021. (AP foto/Seth Wenig, File)
Image

Overview

  • U.S. Bankruptcy Judge Sean Lane confirmed the plan on Nov. 18, ordering Sackler family members to contribute up to $7 billion over 15 years.
  • About $850 million is reserved for individuals, with payments projected next year of roughly $8,000 to $16,000 for those who can document OxyContin prescriptions.
  • Purdue will be replaced by public‑benefit company Knoa Pharma, Sacklers will relinquish ownership, and a trove of internal records will be made public.
  • Most funds will go to state, local and tribal governments for opioid abatement, with states reporting expected allocations such as Massachusetts receiving up to $105 million over 15 years.
  • The agreement replaces a plan the Supreme Court rejected and preserves the right of nonparticipants to sue Sackler family members, as advocates warn many claims may be denied for lack of documentation.